Need Help?

Targeted sequencing of breast cancer susceptibility genes for 1,995 Japanese breast cancer patients

This dataset consists of 106 bam files. Each sample from 10-20 consecutive patient extractions were combined into one DNA pool, generating a total of 106 DNA pools. We sequenced 11 genes implicated in hereditary breast cancer using the SureSelect Custom kit.

Request Access

Data access policy for targeted sequencing data of 1,995 Japanese breast cancer patients

DATA ACCESS AGREEMENT These terms and conditions govern access to the managed access datasets (details of which are set out in Appendix I) to which the User Institution has requested access. The User Institution agrees to be bound by these terms and conditions. Definitions Authorised Personnel: The individuals at the User Institution to whom Department of Pathology and Tumor Biology, Kyoto University Data Access Committee grants access to the Data. This includes the User, the individuals listed in Appendix II and any other individuals for whom the User Institution subsequently requests access to the Data. Details of the initial Authorised Personnel are set out in Appendix II. Data: The managed access datasets to which the User Institution has requested access. Data Producers: Department of Pathology and Tumor Biology, Kyoto University and the collaborators listed in Appendix I responsible for the development, organisation, and oversight of these Data. External Collaborator: A collaborator of the User, working for an institution other than the User Institution. Project: The project for which the User Institution has requested access to these Data. A description of the Project is set out in Appendix II. Publications: Includes, without limitation, articles published in print journals, electronic journals, reviews, books, posters and other written and verbal presentations of research. Research Participant: An individual whose data form part of these Data. Research Purposes: Shall mean research that is seeking to advance the understanding of genetics and genomics, including the treatment of disorders, and work on statistical methods that may be applied to such research. User: The principal investigator for the Project. User Institution(s): The Institution that has requested access to the Data. 1. The User Institution agrees to only use these Data for the purpose of the Project (described in Appendix II) and only for Research Purposes. The User Institution further agrees that it will only use these Data for Research Purposes which are within the limitations (if any) set out in Appendix I. 2. The User Institution agrees to preserve, at all times, the confidentiality of these Data. In particular, it undertakes not to use, or attempt to use these Data to compromise or otherwise infringe the confidentiality of information on Research Participants. Without prejudice to the generality of the foregoing, the User Institution agrees to use at least the measures set out in Appendix I to protect these Data. 3. The User Institution agrees to protect the confidentiality of Research Participants in any research papers or publications that they prepare by taking all reasonable care to limit the possibility of identification. 4. The User Institution agrees not to link or combine these Data to other information or archived data available in a way that could re-identify the Research Participants, even if access to that data has been formally granted to the User Institution or is freely available without restriction. 5. The User Institution agrees only to transfer or disclose these Data, in whole or part, or any material derived from these Data, to the Authorised Personnel. Should the User Institution wish to share these Data with an External Collaborator, the External Collaborator must complete a separate application for access to these Data. 6. The User Institution agrees that the Data Producers, and all other parties involved in the creation, funding or protection of these Data: a) make no warranty or representation, express or implied as to the accuracy, quality or comprehensiveness of these Data; b) exclude to the fullest extent permitted by law all liability for actions, claims, proceedings, demands, losses (including but not limited to loss of profit), costs, awards damages and payments made by the Recipient that may arise (whether directly or indirectly) in any way whatsoever from the Recipient’s use of these Data or from the unavailability of, or break in access to, these Data for whatever reason and; c) bear no responsibility for the further analysis or interpretation of these Data. 7. The User Institution agrees to follow the Fort Lauderdale Guidelines ( ) and the Toronto Statement ( This includes but is not limited to recognising the contribution of the Data Producers and including a proper acknowledgement in all reports or publications resulting from the use of these Data. 8. The User Institution agrees to follow the Publication Policy in Appendix III. This includes respecting the moratorium period for the Data Producers to publish the first peer-reviewed report describing and analysing these Data. 9. The User Institution agrees not to make intellectual property claims on these Data and not to use intellectual property protection in ways that would prevent or block access to, or use of, any element of these Data, or conclusion drawn directly from these Data. 10. The User Institution can elect to perform further research that would add intellectual and resource capital to these data and decide to obtain intellectual property rights on these downstream discoveries. In this case, the User Institution agrees to implement licensing policies that will not obstruct further research and to follow the U.S. National Institutes of Health Best Practices for the Licensing of Genomic Inventions (2005) ( ) in conformity with the Organisation for Economic Co-operation and Development Guidelines for the Licensing of the Genetic Inventions (2006) ( ). 11. The User Institution agrees to destroy/discard the Data held, once it is no longer used for the Project, unless obliged to retain the data for archival purposes in conformity with audit or legal requirements. 12. The User Institution will notify Department of Pathology and Tumor Biology, Kyoto University Data Access Committee within 30 days of any changes or departures of Authorised Personnel. 13. The User Institution will notify Department of Pathology and Tumor Biology, Kyoto University Data Access Committee prior to any significant changes to the protocol for the Project. 14. The User Institution will notify Department of Pathology and Tumor Biology, Kyoto University Data Access Committee as soon as it becomes aware of a breach of the terms or conditions of this agreement. 15. Department of Pathology and Tumor Biology, Kyoto University Data Access Committee may terminate this agreement by written notice to the User Institution. If this agreement terminates for any reason, the User Institution will be required to destroy any Data held, including copies and backup copies. This clause does not prevent the User Institution from retaining these data for archival purpose in conformity with audit or legal requirements. 16. The User Institution accepts that it may be necessary for the Data Producers to alter the terms of this agreement from time to time. As an example, this may include specific provisions relating to the Data required by Data Producers other than Department of Pathology and Tumor Biology, Kyoto University. In the event that changes are required, the Data Producers or their appointed agent will contact the User Institution to inform it of the changes and the User Institution may elect to accept the changes or terminate the agreement. 17. If requested, the User Institution will allow data security and management documentation to be inspected to verify that it is complying with the terms of this agreement. 18. The User Institution agrees to distribute a copy of these terms to the Authorised Personnel. The User Institution will procure that the Authorised Personnel comply with the terms of this agreement. 19. This agreement (and any dispute, controversy, proceedings or claim of whatever nature arising out of this agreement or its formation) shall be construed, interpreted and governed by the laws of Japan and shall be subject to the exclusive jurisdiction of the Japanese courts.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS00001004630 Other
ID File Type Size Located in
EGAF00004457788 bam 2.4 GB
EGAF00004457789 bam 1.9 GB
EGAF00004457790 bam 2.6 GB
EGAF00004457791 bam 2.6 GB
EGAF00004457792 bam 2.2 GB
EGAF00004457793 bam 2.5 GB
EGAF00004457794 bam 2.4 GB
EGAF00004457795 bam 2.5 GB
EGAF00004457796 bam 2.4 GB
EGAF00004457797 bam 2.4 GB
EGAF00004457798 bam 2.9 GB
EGAF00004457799 bam 2.6 GB
EGAF00004457800 bam 2.5 GB
EGAF00004457801 bam 2.8 GB
EGAF00004457802 bam 2.7 GB
EGAF00004457803 bam 2.4 GB
EGAF00004457804 bam 2.4 GB
EGAF00004457805 bam 2.2 GB
EGAF00004457806 bam 1.9 GB
EGAF00004457807 bam 1.8 GB
EGAF00004457808 bam 1.9 GB
EGAF00004457809 bam 2.0 GB
EGAF00004457810 bam 2.1 GB
EGAF00004457811 bam 2.0 GB
EGAF00004457812 bam 1.9 GB
EGAF00004457813 bam 1.9 GB
EGAF00004457814 bam 1.6 GB
EGAF00004457815 bam 1.5 GB
EGAF00004457816 bam 1.6 GB
EGAF00004457817 bam 1.8 GB
EGAF00004457818 bam 1.9 GB
EGAF00004457819 bam 1.6 GB
EGAF00004457820 bam 1.7 GB
EGAF00004457821 bam 1.4 GB
EGAF00004457822 bam 2.8 GB
EGAF00004457823 bam 2.8 GB
EGAF00004457824 bam 2.7 GB
EGAF00004457825 bam 2.8 GB
EGAF00004457826 bam 2.7 GB
EGAF00004457827 bam 2.9 GB
EGAF00004457828 bam 2.8 GB
EGAF00004457829 bam 3.1 GB
EGAF00004457830 bam 2.9 GB
EGAF00004457831 bam 2.7 GB
EGAF00004457832 bam 2.8 GB
EGAF00004457833 bam 2.7 GB
EGAF00004457834 bam 2.7 GB
EGAF00004457835 bam 2.9 GB
EGAF00004457836 bam 2.7 GB
EGAF00004457837 bam 2.8 GB
EGAF00004457838 bam 2.9 GB
EGAF00004457839 bam 2.9 GB
EGAF00004457840 bam 2.8 GB
EGAF00004457841 bam 2.8 GB
EGAF00004457842 bam 2.9 GB
EGAF00004457843 bam 2.9 GB
EGAF00004457844 bam 2.8 GB
EGAF00004457845 bam 2.7 GB
EGAF00004457846 bam 2.4 GB
EGAF00004457847 bam 2.0 GB
EGAF00004457848 bam 2.7 GB
EGAF00004457849 bam 2.4 GB
EGAF00004457850 bam 2.5 GB
EGAF00004457851 bam 2.6 GB
EGAF00004457852 bam 2.5 GB
EGAF00004457853 bam 2.6 GB
EGAF00004457854 bam 2.0 GB
EGAF00004457855 bam 2.2 GB
EGAF00004457856 bam 1.9 GB
EGAF00004457857 bam 2.5 GB
EGAF00004457858 bam 2.1 GB
EGAF00004457859 bam 2.1 GB
EGAF00004457860 bam 2.6 GB
EGAF00004457861 bam 2.4 GB
EGAF00004457862 bam 1.9 GB
EGAF00004457863 bam 2.5 GB
EGAF00004457864 bam 2.4 GB
EGAF00004457865 bam 2.2 GB
EGAF00004457866 bam 2.4 GB
EGAF00004457867 bam 2.5 GB
EGAF00004457868 bam 2.5 GB
EGAF00004457869 bam 2.2 GB
EGAF00004457870 bam 2.2 GB
EGAF00004457871 bam 1.8 GB
EGAF00004457872 bam 1.8 GB
EGAF00004457873 bam 1.9 GB
EGAF00004457874 bam 2.2 GB
EGAF00004457875 bam 2.0 GB
EGAF00004457876 bam 2.2 GB
EGAF00004457877 bam 2.1 GB
EGAF00004457878 bam 1.8 GB
EGAF00004457879 bam 1.6 GB
EGAF00004457880 bam 1.9 GB
EGAF00004457881 bam 1.8 GB
EGAF00004457882 bam 2.6 GB
EGAF00004457883 bam 2.8 GB
EGAF00004457884 bam 2.8 GB
EGAF00004457885 bam 2.5 GB
EGAF00004457886 bam 2.5 GB
EGAF00004457887 bam 1.9 GB
EGAF00004457888 bam 2.5 GB
EGAF00004457889 bam 2.6 GB
EGAF00004457890 bam 2.2 GB
EGAF00004457891 bam 2.5 GB
EGAF00004457892 bam 2.8 GB
EGAF00004457893 bam 2.7 GB
106 Files (250.6 GB)